Will ‘Valsartan’ incident eradicate Chinese APIs in Korea?

Published: 2018-08-17 17:18:41

Updated: 2018-08-17 17:18:41

People have started to concern about Chinese active pharmaceutical ingredients(APIs) more and more due to the incident of Valsartan ingredients with potential carcinogenic substances.

The pharmaceutical industry has been active in considering to use less Chinese active pharmaceutical ingredients and changing their supply chain to acquire these ingredients.

After detecting ‘N-Nitrosodimethylam...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.